Venus Remedies Renews GMP Certification in Ukraine for Baddi Facility Producing Antibiotics and Oncology Injectables

Venus Remedies has successfully renewed its Good Manufacturing Practices (GMP) certification in Ukraine for its Unit-II manufacturing facility located in Baddi, Himachal Pradesh. The certification encompasses the production lines for cephalosporin, non-cephalosporin (carbapenem), and oncology parenteral products, including both liquid and lyophilized injections.

The renewal confirms compliance with Ukrainian regulatory standards for pharmaceutical manufacturing at the facility. This certification applies specifically to critical production areas that handle antibiotics and oncology-related injectable medications. The approval underscores the facility’s adherence to stringent quality control measures required for international markets.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: May 22, 2025

Related posts:

Biosimilars Reduce Rheumatoid Arthritis Treatment Costs: *Journal of Managed Care & Specialty Pharmacy* Study Drug Patent Watch: Digital Transformation Streamlines Generic Drug Development, Offering Efficiencies in Cost, Time and Quality Kennedy’s MAHA Commission on Childhood Chronic Disease Faces May 24 Deadline After Single Meeting BridgeBio’s New Heart Medication Sees Strong Early Demand After Approval

Author

Mark Chiang